971 related articles for article (PubMed ID: 22522673)
41. Parotid gland metastasis in Merkel cell carcinoma of the head and neck: A series of 14 cases.
Day KE; Carroll WR; Rosenthal EL
Ear Nose Throat J; 2016 Sep; 95(9):398-404. PubMed ID: 27657318
[TBL] [Abstract][Full Text] [Related]
42. Merkel cell carcinoma of the head and neck.
Suárez C; Rodrigo JP; Ferlito A; Devaney KO; Rinaldo A
Oral Oncol; 2004 Sep; 40(8):773-9. PubMed ID: 15288830
[TBL] [Abstract][Full Text] [Related]
43. Predictors of survival and recurrence in the surgical treatment of merkel cell carcinoma of the extremities.
Senchenkov A; Barnes SA; Moran SL
J Surg Oncol; 2007 Mar; 95(3):229-34. PubMed ID: 17323336
[TBL] [Abstract][Full Text] [Related]
44. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
[TBL] [Abstract][Full Text] [Related]
45. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.
Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713
[TBL] [Abstract][Full Text] [Related]
46. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin.
Mojica P; Smith D; Ellenhorn JD
J Clin Oncol; 2007 Mar; 25(9):1043-7. PubMed ID: 17369567
[TBL] [Abstract][Full Text] [Related]
47. Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation.
Arron ST; Canavan T; Yu SS
J Am Acad Dermatol; 2014 Oct; 71(4):684-90. PubMed ID: 24993599
[TBL] [Abstract][Full Text] [Related]
48. The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients.
Chen MM; Roman SA; Sosa JA; Judson BL
JAMA Otolaryngol Head Neck Surg; 2015 Feb; 141(2):137-41. PubMed ID: 25474617
[TBL] [Abstract][Full Text] [Related]
49. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
[TBL] [Abstract][Full Text] [Related]
50. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
51. Merkel cell carcinoma of the hand.
Parcells AL; Lee ES; Fleegler EJ
J Hand Surg Am; 2014 Jul; 39(7):1421-3, quiz 1424. PubMed ID: 24679492
[No Abstract] [Full Text] [Related]
52. Rising incidence of Merkel cell carcinoma.
Lyhne D; Lock-Andersen J; Dahlstrøm K; Drzewiecki KT; Balslev E; Muhic A; Krarup-Hansen A
J Plast Surg Hand Surg; 2011 Dec; 45(6):274-80. PubMed ID: 22250719
[TBL] [Abstract][Full Text] [Related]
53. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
54. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
55. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Allison RS; Chaplin JM; Gregor RT; Lea R; Tan ST
J Surg Oncol; 2008 Aug; 98(2):101-5. PubMed ID: 18523982
[TBL] [Abstract][Full Text] [Related]
56. P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survival.
Vlahova L; Doerflinger Y; Houben R; Becker JC; Schrama D; Weiss C; Goebeler M; Helmbold P; Goerdt S; Peitsch WK
Br J Dermatol; 2012 May; 166(5):1043-52. PubMed ID: 22283194
[TBL] [Abstract][Full Text] [Related]
57. Merkel cell carcinoma.
Liao PB
Dermatol Ther; 2008; 21(6):447-51. PubMed ID: 19076622
[TBL] [Abstract][Full Text] [Related]
58. Merkel cell carcinoma of the head and neck: emphasizing the risk of undertreatment.
Timmer FC; Klop WM; Relyveld GN; Crijns MB; Balm AJ; van den Brekel MW; Lohuis PJ
Eur Arch Otorhinolaryngol; 2016 May; 273(5):1243-51. PubMed ID: 25759258
[TBL] [Abstract][Full Text] [Related]
59. Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck.
Veness MJ; Morgan GJ; Gebski V
Head Neck; 2005 Mar; 27(3):208-16. PubMed ID: 15627249
[TBL] [Abstract][Full Text] [Related]
60. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data.
Turner JH; Richmon JD
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):967-73. PubMed ID: 21873599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
